Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
40.66
+0.70 (1.75%)
At close: Apr 20, 2026
SHA:603102 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,092 | 1,135 | 1,135 | 1,136 | 1,100 | 414.17 |
Cash & Short-Term Investments | 1,092 | 1,135 | 1,135 | 1,136 | 1,100 | 414.17 |
Cash Growth | -2.50% | 0.07% | -0.09% | 3.27% | 165.51% | 7.66% |
Accounts Receivable | 135.13 | 122.06 | 83.59 | 54.05 | 47.05 | 34.63 |
Other Receivables | 1.67 | 1.75 | 1.05 | 1.25 | 5.83 | 1.48 |
Receivables | 136.79 | 123.8 | 84.63 | 55.3 | 52.88 | 36.12 |
Inventory | 136.87 | 142.56 | 115.12 | 124.61 | 147.08 | 111.7 |
Other Current Assets | 62.16 | 18.03 | 19.38 | 10.49 | 7.82 | 5.25 |
Total Current Assets | 1,427 | 1,420 | 1,354 | 1,326 | 1,307 | 567.25 |
Property, Plant & Equipment | 434.82 | 438.04 | 400.25 | 353.48 | 315.85 | 311.89 |
Goodwill | 34.58 | 35.12 | 0.52 | 0.52 | 0.52 | 0.52 |
Other Intangible Assets | 51.93 | 52.44 | 49.3 | 44.74 | 27.15 | 22.41 |
Long-Term Deferred Tax Assets | 4.7 | 3.95 | 1.64 | 1.97 | 1.89 | 1.64 |
Long-Term Deferred Charges | 1.25 | 1.32 | 0.83 | - | - | - |
Other Long-Term Assets | 6.87 | 4.87 | 9.45 | 9.44 | 9.12 | 12.2 |
Total Assets | 1,962 | 1,956 | 1,816 | 1,736 | 1,662 | 915.92 |
Accounts Payable | 103.07 | 117.18 | 96.06 | 92.47 | 82.34 | 72.04 |
Accrued Expenses | 12.91 | 17.01 | 17.18 | 18.87 | 18.49 | 14.95 |
Current Portion of Long-Term Debt | 4.43 | 3.79 | - | - | - | - |
Current Portion of Leases | - | - | 0.15 | 1.95 | 0.62 | 1.14 |
Current Income Taxes Payable | 21.92 | 21.56 | 4.4 | 5.43 | 4.42 | 0.44 |
Current Unearned Revenue | 51.01 | 56.48 | 42.25 | 45.35 | 68.72 | 41.41 |
Other Current Liabilities | 23.67 | 24.25 | 33.04 | 39.53 | 42.49 | 48.47 |
Total Current Liabilities | 217 | 240.26 | 193.08 | 203.6 | 217.09 | 178.45 |
Long-Term Leases | 11.01 | 10.57 | 0.05 | - | 1.95 | 2.32 |
Long-Term Unearned Revenue | 13.25 | 13.91 | 16.68 | 18.1 | 20.9 | 21.43 |
Other Long-Term Liabilities | 4.75 | 4.75 | - | - | - | - |
Total Liabilities | 246.02 | 269.48 | 209.81 | 221.7 | 239.93 | 202.2 |
Common Stock | 64 | 64 | 64 | 64 | 64 | 48 |
Additional Paid-In Capital | 654.95 | 654.95 | 654.95 | 654.95 | 654.95 | 68.46 |
Retained Earnings | 1,036 | 1,008 | 925.84 | 833.77 | 703.1 | 597.26 |
Treasury Stock | -68.88 | -68.88 | -38.86 | -38.25 | - | - |
Comprehensive Income & Other | -3.84 | -2.2 | - | - | - | - |
Total Common Equity | 1,683 | 1,655 | 1,606 | 1,514 | 1,422 | 713.72 |
Minority Interest | 32.86 | 30.6 | - | - | - | - |
Shareholders' Equity | 1,716 | 1,686 | 1,606 | 1,514 | 1,422 | 713.72 |
Total Liabilities & Equity | 1,962 | 1,956 | 1,816 | 1,736 | 1,662 | 915.92 |
Total Debt | 15.44 | 14.36 | 0.2 | 1.95 | 2.57 | 3.46 |
Net Cash (Debt) | 1,076 | 1,121 | 1,134 | 1,134 | 1,097 | 410.71 |
Net Cash Growth | -3.22% | -1.18% | 0.07% | 3.33% | 167.12% | 6.76% |
Net Cash Per Share | 17.26 | 17.89 | 17.75 | 17.70 | 17.51 | 8.54 |
Filing Date Shares Outstanding | 62.83 | 62.71 | 62.89 | 62.98 | 64 | 48 |
Total Common Shares Outstanding | 62.83 | 62.71 | 62.98 | 63 | 64 | 48 |
Working Capital | 1,210 | 1,180 | 1,161 | 1,122 | 1,090 | 388.8 |
Book Value Per Share | 26.78 | 26.40 | 25.50 | 24.04 | 22.22 | 14.87 |
Tangible Book Value | 1,596 | 1,568 | 1,556 | 1,469 | 1,394 | 690.79 |
Tangible Book Value Per Share | 25.41 | 25.00 | 24.71 | 23.32 | 21.79 | 14.39 |
Buildings | - | - | 252.67 | 228.89 | 207.62 | 204.83 |
Machinery | - | - | 312.52 | 273.45 | 241.23 | 215.17 |
Construction In Progress | - | - | 52.68 | 30.7 | 17.07 | 14.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.